BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 30987013)

  • 1. Concomitant Expression of Prolactin Receptor and TGFβ Receptors in Breast Cancer: Association with Less Aggressive Phenotype and Favorable Patient Outcome.
    Hachim IY; López-Ozuna VM; Hachim MY; Lebrun JJ; Ali S
    Int J Mol Sci; 2019 Apr; 20(7):. PubMed ID: 30987013
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prolactin Receptor Expression is an Independent Favorable Prognostic Marker in Human Breast Cancer.
    Hachim IY; Hachim MY; Lopez VM; Lebrun JJ; Ali S
    Appl Immunohistochem Mol Morphol; 2016 Apr; 24(4):238-45. PubMed ID: 26317306
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A dual prognostic role for the TGFβ receptors in human breast cancer.
    Hachim IY; Hachim MY; López-Ozuna VM; Ali S; Lebrun JJ
    Hum Pathol; 2016 Nov; 57():140-151. PubMed ID: 27445263
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A favorable role of prolactin in human breast cancer reveals novel pathway-based gene signatures indicative of tumor differentiation and favorable patient outcome.
    Hachim IY; Shams A; Lebrun JJ; Ali S
    Hum Pathol; 2016 Jul; 53():142-52. PubMed ID: 26980025
    [TBL] [Abstract][Full Text] [Related]  

  • 5. MicroRNA-9 is associated with epithelial-mesenchymal transition, breast cancer stem cell phenotype, and tumor progression in breast cancer.
    Gwak JM; Kim HJ; Kim EJ; Chung YR; Yun S; Seo AN; Lee HJ; Park SY
    Breast Cancer Res Treat; 2014 Aug; 147(1):39-49. PubMed ID: 25086633
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Differential expression of TGFβ isoforms in breast cancer highlights different roles during breast cancer progression.
    Hachim MY; Hachim IY; Dai M; Ali S; Lebrun JJ
    Tumour Biol; 2018 Jan; 40(1):1010428317748254. PubMed ID: 29320969
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A role for kinesin-1 subunits KIF5B/KLC1 in regulating epithelial mesenchymal plasticity in breast tumorigenesis.
    Moamer A; Hachim IY; Binothman N; Wang N; Lebrun JJ; Ali S
    EBioMedicine; 2019 Jul; 45():92-107. PubMed ID: 31204277
    [TBL] [Abstract][Full Text] [Related]  

  • 8. An increased transforming growth factor beta receptor type I:type II ratio contributes to elevated collagen protein synthesis that is resistant to inhibition via a kinase-deficient transforming growth factor beta receptor type II in scleroderma.
    Pannu J; Gore-Hyer E; Yamanaka M; Smith EA; Rubinchik S; Dong JY; Jablonska S; Blaszczyk M; Trojanowska M
    Arthritis Rheum; 2004 May; 50(5):1566-77. PubMed ID: 15146427
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Foxf2 plays a dual role during transforming growth factor beta-induced epithelial to mesenchymal transition by promoting apoptosis yet enabling cell junction dissolution and migration.
    Meyer-Schaller N; Heck C; Tiede S; Yilmaz M; Christofori G
    Breast Cancer Res; 2018 Oct; 20(1):118. PubMed ID: 30285803
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Role of Prolactin in Bone Metastasis and Breast Cancer Cell-Mediated Osteoclast Differentiation.
    Sutherland A; Forsyth A; Cong Y; Grant L; Juan TH; Lee JK; Klimowicz A; Petrillo SK; Hu J; Chan A; Boutillon F; Goffin V; Egan C; Tang PA; Cai L; Morris D; Magliocco A; Shemanko CS
    J Natl Cancer Inst; 2016 Mar; 108(3):. PubMed ID: 26586670
    [TBL] [Abstract][Full Text] [Related]  

  • 11. FUT8 promotes breast cancer cell invasiveness by remodeling TGF-β receptor core fucosylation.
    Tu CF; Wu MY; Lin YC; Kannagi R; Yang RB
    Breast Cancer Res; 2017 Oct; 19(1):111. PubMed ID: 28982386
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Nucleostemin expression in breast cancer is a marker of more aggressive phenotype and unfavorable patients' outcome: A STROBE-compliant article.
    Sami MM; Hachim MY; Hachim IY; Elbarkouky AH; López-Ozuna VM
    Medicine (Baltimore); 2019 Mar; 98(9):e14744. PubMed ID: 30817632
    [TBL] [Abstract][Full Text] [Related]  

  • 13. TGFβ isoforms and receptors mRNA expression in breast tumours: prognostic value and clinical implications.
    Chen C; Zhao KN; Masci PP; Lakhani SR; Antonsson A; Simpson PT; Vitetta L
    BMC Cancer; 2015 Dec; 15():1010. PubMed ID: 26703884
    [TBL] [Abstract][Full Text] [Related]  

  • 14. TGFbeta signaling is necessary for carcinoma cell invasiveness and metastasis.
    Oft M; Heider KH; Beug H
    Curr Biol; 1998 Nov; 8(23):1243-52. PubMed ID: 9822576
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prolactin/androgen-inducible carboxypeptidase-D increases with nitrotyrosine and Ki67 for breast cancer progression in vivo, and upregulates progression markers VEGF-C and Runx2 in vitro.
    Thomas LN; Chedrawe ER; Barnes PJ; Too CKL
    Breast Cancer Res Treat; 2017 Jul; 164(1):27-40. PubMed ID: 28364216
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Expression of embryonal stem cell transcription factors in breast cancer: Oct4 as an indicator for poor clinical outcome and tamoxifen resistance.
    Gwak JM; Kim M; Kim HJ; Jang MH; Park SY
    Oncotarget; 2017 May; 8(22):36305-36318. PubMed ID: 28422735
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prolactin Pro-Differentiation Pathway in Triple Negative Breast Cancer: Impact on Prognosis and Potential Therapy.
    López-Ozuna VM; Hachim IY; Hachim MY; Lebrun JJ; Ali S
    Sci Rep; 2016 Aug; 6():30934. PubMed ID: 27480353
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The dual role of FOXF2 in regulation of DNA replication and the epithelial-mesenchymal transition in breast cancer progression.
    Lo PK; Lee JS; Liang X; Sukumar S
    Cell Signal; 2016 Oct; 28(10):1502-19. PubMed ID: 27377963
    [TBL] [Abstract][Full Text] [Related]  

  • 19. HR+HER2- breast cancers with growth factor receptor-mediated EMT have a poor prognosis and lapatinib downregulates EMT in MCF-7 cells.
    Desai K; Aiyappa R; Prabhu JS; Nair MG; Lawrence PV; Korlimarla A; Ce A; Alexander A; Kaluve RS; Manjunath S; Correa M; Srinath BS; Patil S; Kalamdani A; Prasad M; Sridhar TS
    Tumour Biol; 2017 Mar; 39(3):1010428317695028. PubMed ID: 28349782
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Fucoidan induces changes in the epithelial to mesenchymal transition and decreases metastasis by enhancing ubiquitin-dependent TGFβ receptor degradation in breast cancer.
    Hsu HY; Lin TY; Hwang PA; Tseng LM; Chen RH; Tsao SM; Hsu J
    Carcinogenesis; 2013 Apr; 34(4):874-84. PubMed ID: 23275155
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.